Chacón López-Muñiz, J. I. http://orcid.org/0000-0002-1286-6157
de la Cruz Merino, L.
Gavilá Gregori, J.
Martínez Dueñas, E.
Oliveira, M.
Seguí Palmer, M. A.
Álvarez López, I.
Antolin Novoa, S.
Bellet Ezquerra, M.
López-Tarruella Cobo, S.
Article History
Received: 3 December 2018
Accepted: 5 December 2018
First Online: 8 January 2019
Compliance with ethical standards
:
: JICH reports advisory boards and travel grants from Bristol Myers Squibb, Roche, Novartis, Celgene, Pierre Fabre, Astrazeneca, Shire, MSD, Merck and Pfizer, outside the submitted work. LCM reports advisory boards and speaking from Bristol Myers Squibb, MSD, Merck, Novartis and Roche, and Research Grants from MSD, Merck, Celgene and Roche. JG reports personal fees from Roche and Novartis during the conduct of the study. EMD reports speaker fees and advisory boards from Pfizer, Novartis, AstraZeneca, Eisai, Pierre-Fabre and Roche, personal fees from Roche, and Coordinator of electronic book of breast cancer sponsored by Novartis. MO reports personal fees from Roche/Genentech, outside the submitted work. MAS reports personal fees and non-financial support from Roche, Pfizer and Novartis, and personal fees from EISAI, outside the submitted work. IA reports personal fees from Pfizer, Novartis, Roche, Astrazeneca y Palex, non financial-support from Pfizer and Roche, and grants from Pfizer, Novartis, Roche and Astrazeneca during the conduct of the study. SA has nothing to disclose. MB reports advisory boards from Pfizer, Novartis and Lilly, honoraria from Novrtis and Pfizer and travel grants from Pfizer and Roche, outside the submitted work, SLT reports personal fees from Astra Zeneca, Novartis, Roche, Pfizer, Celgene, Pierre Fabre, Eisai; non-financial support from Novartis, Celgene, Pfizer and Pierre Fabre during the conduct of the study.
: The current study has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: For this type of study formal consent is not required.